Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

NCT06485713 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer
Drug Therapy

Interventions

DRUG: trifluridine/tipiracil combined with fufuquitinib
DRUG: fufuquitinib
DRUG: Trifluridine/tipiracil

Sponsor

First Affiliated Hospital of Wenzhou Medical University